Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESEP: Discontinuation of Antipsychotics and Antidepressants in Dementia
NCT00594269Phase 4Completed
- Sponsor
- Sykehuset Innlandet
- Start
- Aug 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of risperidone, escitalopram, citalopram, sertraline and paroxetine in Dementia, sponsored by Sykehuset Innlandet. Started Aug 2008; status: completed.
02
Drugs
risperidoneescitalopramcitalopramsertralineparoxetine
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT00594269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594269.